News

Denmark's Novo Nordisk is partnering with biotech company Deep Apple Therapeutics in a deal worth up to $812 million to ...
Excess fat mass estimated by waist circumference-to-height ratio predicts the risk of liver damage better than body mass ...
Looking to nature for answers to complex questions can reveal new and unprecedented results that can even affect cells on ...
CompanyOverview|NYSE:NVO] Despite a massively successful run as Chief Executive Officer (CEO) of pharma giant Novo Nordisk ...
Comedian Robby Hoffman, designer Clint419, and WNBA stylist Brittany Hampton are people you should know making an impact in ...
The Green Steel Market, valued at USD 7.4 billion in 2024, is expected to reach USD 19.4 billion by 2029, growing at a CAGR ...
The brand’s new logo is as serendipitous as it is straightforward, but no less sublime. It almost feels like an intervention ...
Mexico's antitrust watchdog is set to rule by next week on whether Google built an illegal monopoly in digital advertising in ...
Within Novo Nordisk's comprehensive business update to investors, attention latched onto early data for an oral obesity therapy that outperformed the company’s big-selling GLP-1 agonist Wegovy ...
Novo Nordisk has reported new data with its long-acting human growth hormone (hGH) product Sogroya, showing it is at least as effective as its older drug Norditropin in various paediatric growth ...
The science of stamina has advanced to the point where individuals, teams, and whole organizations can, with some straightforward interventions, significantly increase their capacity to get things ...